AvoMD, a no-code platform that allows clinicians and hospitals to create their own apps for use at the point-of-care, has announced the closure of a $5 million seed funding round. The funding was led by early-stage venture fund AlleyCorp, with participation from investors such as Las Olas, Epsilon Health, MedMountain Ventures, notable physician angel investors, and existing investors Mirae and Dunamu. Additional investors include Columbia University, Mount Sinai Innovation Partners, StartUp Health, and 500 Startups.
AvoMD provides an AI-enabled, no-code application builder that enables clinicians and hospitals to develop custom applications for various specialties and care settings. The platform supports use cases such as interactive clinical guidelines, medical calculators, billing support, and documentation automation. AvoMD has already established standardized integrations with major electronic health record systems in the US, allowing for efficient deployment. The platform also facilitates the integration of AI models, enabling clinicians to incorporate clinical predictions based on AI at the point of care.
The company was founded by a team of physicians in New York City who experienced clinical burnout and the challenges of developing and implementing innovative clinical applications firsthand. AvoMD aims to transform the creation and use of clinical technology, saving clinicians time and improving patient outcomes.
AvoMD’s Chairman and Head of Product/Engineering, Dr. Joongheum Park, expressed excitement about the partnership with AlleyCorp and the company’s vision for empowering clinicians to deliver high-quality care. The founding team includes Dr. Yair Saperstein, a physician-technologist with experience in delivering care on the frontlines, and Laurence Coman, who brings prior software investing experience.
AlleyCorp Healthcare, the lead investor, highlighted the value of AvoMD’s platform and its understanding of the unique challenges faced by doctors. They recognized the impact of integrating clinical evidence into workflows and the potential for technology to alleviate burnout and enhance patient outcomes. The rapid adoption of AvoMD’s product by clinicians across various settings was also cited as a reason for support.
